NCT06924840View on ClinicalTrials.gov

A Clinical Study to Assess the Safety and Effectiveness of Utixira Lotion and Utixira Tablet in Healthy Adult Human Subjects With Dry or Sensitive Skin Prone to Mild to Moderate Pruritus and Urticaria

NANot yet recruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

June 15, 2025

Study Completion Date

June 15, 2025

Conditions
Dry SkinUrticariaPruritusSensitive
Interventions
OTHER

Utixira Lotion tablet as regimen

"Mode of Usage: To be applied over the affected areas twice a day as a thin film and rubbed in gently and completely. Take 1 capsule twice a day for better results.~Marketed By: SAVA Healthcare Ltd Frequency: Twice a Day"

All Listed Sponsors
lead

SAVA Healthcare Limited

OTHER

NCT06924840 - A Clinical Study to Assess the Safety and Effectiveness of Utixira Lotion and Utixira Tablet in Healthy Adult Human Subjects With Dry or Sensitive Skin Prone to Mild to Moderate Pruritus and Urticaria | Biotech Hunter | Biotech Hunter